关注
Sasisopin Kiertiburanakul
Sasisopin Kiertiburanakul
Faculty of Medicine Ramathibodi Hospital, Mahidol University, Department of Medicine
在 mahidol.ac.th 的电子邮件经过验证
标题
引用次数
引用次数
年份
Major clinical outcomes in antiretroviral therapy (ART)–naive participants and in those not receiving ART at baseline in the SMART study
Strategies for Management of Antiretroviral Therapy (SMART) Study Group
The Journal of infectious diseases 197 (8), 1133-1144, 2008
5792008
Adult-onset immunodeficiency in Thailand and Taiwan
SK Browne, PD Burbelo, P Chetchotisakd, Y Suputtamongkol, ...
New England Journal of Medicine 367 (8), 725-734, 2012
5132012
CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial
J Ananworanich, A Gayet-Ageron, M Le Braz, W Prasithsirikul, ...
The Lancet 368 (9534), 459-465, 2006
2882006
Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient-and sequence-level meta-analysis
SY Rhee, JL Blanco, MR Jordan, J Taylor, P Lemey, V Varghese, ...
PLoS medicine 12 (4), e1001810, 2015
2822015
Inferior Clinical Outcome of the CD4+ Cell Count–Guided Antiretroviral Treatment Interruption Strategy in the SMART Study: Role of CD4+ Cell Counts and HIV …
Strategies for Management of Antiretroviral Therapy (SMART) Study Group
The Journal of infectious diseases 197 (8), 1145-1155, 2008
2562008
Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails
S Sungkanuparph, W Manosuth, S Kiertiburanakul, B Piyavong, ...
Clinical Infectious Diseases 44 (3), 447-452, 2007
2472007
HLA-B* 3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients
S Chantarangsu, T Mushiroda, S Mahasirimongkol, S Kiertiburanakul, ...
Pharmacogenetics and genomics 19 (2), 139-146, 2009
2232009
Cryptococcosis in human immunodeficiency virus-negative patients
S Kiertiburanakul, S Wirojtananugoon, R Pracharktam, S Sungkanuparph
International journal of infectious diseases 10 (1), 72-78, 2006
2222006
Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy
W Manosuthi, S Kiertiburanakul, T Phoorisri, S Sungkanuparph
Journal of Infection 53 (6), 357-363, 2006
1942006
Long-term virological outcomes of first-line antiretroviral therapy for HIV-1 in low-and middle-income countries: a systematic review and meta-analysis
TS Boender, KCE Sigaloff, JH McMahon, S Kiertiburanakul, MR Jordan, ...
Clinical Infectious Diseases 61 (9), 1453-1461, 2015
1782015
Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial
SMART Study Group*
Annals of internal medicine 149 (5), 289-299, 2008
1652008
Disseminated nontuberculous mycobacterial infection in patients who are not infected with HIV in Thailand
P Chetchotisakd, S Kiertiburanakul, P Mootsikapun, S Assanasen, ...
Clinical infectious diseases 45 (4), 421-427, 2007
1472007
Efavirenz 600 mg/day versus efavirenz 800 mg/day in HIV-infected patients with tuberculosis receiving rifampicin: 48 weeks results
W Manosuthi, S Kiertiburanakul, S Sungkanuparph, K Ruxrungtham, ...
Aids 20 (1), 131-132, 2006
1332006
Efavirenz levels and 24-week efficacy in HIV-infected patients with tuberculosis receiving highly active antiretroviral therapy and rifampicin
W Manosuthi, S Sungkanuparph, A Thakkinstian, A Vibhagool, ...
Aids 19 (14), 1481-1486, 2005
1122005
Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2014, Thailand
W Manosuthi, S Ongwandee, S Bhakeecheep, M Leechawengwongs, ...
AIDS research and therapy 12, 1-9, 2015
1032015
Comparison of clinical features and survival between cryptococcosis in human immunodeficiency virus (HIV)-positive and HIV-negative patients
U Jongwutiwes, S Sungkanuparph, S Kiertiburanakul
Japanese journal of infectious diseases 61 (2), 111-115, 2008
952008
Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study
S Sungkanuparph, A Vibhagool, W Manosuthi, S Kiertiburanakul, ...
J Med Assoc Thai 87 (11), 1349-54, 2004
922004
Adherence to antiretroviral therapy for HIV in sub‐Saharan Africa and Asia: a comparative analysis of two regional cohorts
R Bijker, A Jiamsakul, C Kityo, S Kiertiburanakul, M Siwale, P Phanuphak, ...
Journal of the International AIDS Society 20 (1), 21218, 2017
892017
Anti–IFN-γ autoantibodies are strongly associated with HLA-DR* 15: 02/16: 02 and HLA-DQ* 05: 01/05: 02 across Southeast Asia
CL Ku, CH Lin, SW Chang, CC Chu, JFW Chan, XF Kong, CH Lee, ...
Journal of Allergy and Clinical Immunology 137 (3), 945-948. e8, 2016
782016
Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents: the recommendations of the Thai AIDS Society (TAS) 2008
S Sungkanuparph, T Anekthananon, N Hiransuthikul, ...
Journal of the Medical Association of Thailand 91 (12), 1925, 2011
772011
系统目前无法执行此操作,请稍后再试。
文章 1–20